Brian Case
Chief Tech/Sci/R&D Officer en KORU MEDICAL SYSTEMS, INC. .
Fortuna: 280 250 $ al 31/03/2024
Perfil
Brian Case is currently the Chief Technology Officer at KORU Medical Systems, Inc. Prior to his current position, he served as the Vice President-Research & Development at Fresenius Kabi AG from 2006 to 2022.
Mr. Case holds a graduate degree from Rose-Hulman Institute of Technology, Inc. and an undergraduate degree from the University of Illinois.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
24/03/2024 | 118 750 ( 0.26% ) | 280 250 $ | 31/03/2024 |
Cargos activos de Brian Case
Empresas | Cargo | Inicio |
---|---|---|
KORU MEDICAL SYSTEMS, INC. | Chief Tech/Sci/R&D Officer | 18/04/2022 |
Antiguos cargos conocidos de Brian Case.
Empresas | Cargo | Fin |
---|---|---|
Fresenius Kabi AG
Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Chief Tech/Sci/R&D Officer | 01/05/2022 |
Formación de Brian Case.
Rose-Hulman Institute of Technology, Inc. | Graduate Degree |
University of Illinois | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
KORU MEDICAL SYSTEMS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Fresenius Kabi AG
Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Health Technology |
- Bolsa de valores
- Insiders
- Brian Case